Cardiology
News, opinions and meeting coverage in cardiology.
ESC: Peto Analysis Called Short on Proof of Simvastatin/ Ezetimibe Cancer Safety
SEATTLE -- Simvastatin/ezetimibe (Vytorin) may increase the risk of cancer after all, concluded a leading American biostatistician who dismissed as prematurely reassuring an analysis by Richard Peto, Ph.D., F.R.S., that found the link with excess malignancy to be overblown.
Sep 04, 2008
ACC: Senate Probe Finds Evidence that Drug Firms Worked to Delay ENHANCE Results
CHICAGO -- E-mails made public today described outrage more than a year ago by the ENHANCE trial's principal investigator because he perceived that a drugmaker was withholding bad results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons.
Mar 31, 2008
Heartburn Remedy May Help Treat Heart Failure
SUITA CITY, Japan -- Heart failure patients who added 30 mg of Pepcid (famotidine) to standard therapy significantly improved NYHA functional class and reduced plasma B-type natriuretic peptide levels compared with those given 150 mg of teprenone.
Sep 25, 2006
Blood Clots Linked to Alzheimer's and Vascular Dementias
MANCHESTER, England — Spontaneous cerebral blood clots were detected at similar rates in patients with Alzheimer's disease and vascular dementia, suggesting a common pathology and a potentially preventable or treatable cause for some dementias, researchers here said.
Apr 28, 2006
ACP: Garlic, Ginseng, Ginkgo Biloba, and Ginger All Bad Actors with Coumadin
PHILADELPHIA - When it comes to adverse events associated with Coumadin (warfarin) therapy, beware of herbs and many supplements beginning with the letter G, according to a University of Washington investigator.
Apr 09, 2006
ACC: Coronary Artery Disease Patients Should Have Low LDL Goal
ATLANTA, March 10 - For all patients with stable coronary artery disease (CAD), the goal of therapy should be to get LDL cholesterol lower than 70 mg/dL, said Christie Ballantyne, M.D., director of the center for cardiovascular disease prevention at Baylor College of Medicine in Houston.
Mar 22, 2006
Morphine for Chest Pain Increases ACS Death Risk
DURHAM, N.C.-Morphine to relieve severe chest pain associated with the non-ST-segment elevation acute coronary syndrome may increase the risk of death by nearly 50%, report Duke investigators. They recommend nitroglycerin as first choice.
May 06, 2005
ACC: LDL Cholesterol of Less than 80 mg/dL Reduces Risk of Heart Attack and Stroke
ORLANDO-Cardiologists report that aggressive cholesterol-lowering to new super low target levels of LDL is associated with a 22% reduction in risk of heart attack, stroke, cardiac arrest and death from heart disease for patients with stable coronary disease. The reduction to a mean of 77 mg/dL compared with standard cholesterol-lowering therapy that aims to reduce LDL to about 100 mg/dL. In addition, stroke risk was reduced by 25% compared with risk in patients treated to the recommended target of 100 mg/dL.
Mar 08, 2005
Fiber Supplement Equivalent to Doubling the Dose of Statin
Three servings of psyllium (Metamucil) per day reduced the low-density lipoprotein (LDL) levels of patients on a statin drug by an additional 6%, roughly the same reduction achieved by doubling the statin dose, according to research presented at the American Heart Association 2004 Scientific Sessions.
Nov 10, 2004